13.03.2019 11:56:12
|
Elanco Appoints Four Members To Board
(RTTNews) - Elanco Animal Health Inc. (ELAN) said that it appointed four new members to the Board of Directors. The new members will serve on staggered terms, creating a nine-member Board. The Board was initially established in September 2018 when Elanco became a publicly traded company following its separation from Eli Lilly and Company.
The appointments follow Lilly's full divestiture of Elanco, making Elanco a fully independent company.
The new members of the Elanco Board of Directors include: Deborah Kochevar;Denise Scots-Knight, John (J.P.) Bilbrey, Kirk McDonald.
David Hoover, retired CEO of Ball Corporation, remains as Chairman of the Board of Directors. Other remaining board members include Jeffrey N. Simmons, president and CEO of Elanco; Kapila Kapur Anand, retired KPMG partner; and Lawrence Kurzius, chairman, president and chief executive officer of McCormick & Company.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Elanco Animal Health Inc Registered Shsmehr Nachrichten
06.11.24 |
Ausblick: Elanco Animal Health gewährt Anlegern Blick in die Bücher (finanzen.net) | |
23.10.24 |
Erste Schätzungen: Elanco Animal Health vermeldet Zahlen zum jüngsten Quartal (finanzen.net) | |
07.08.24 |
Ausblick: Elanco Animal Health zieht Bilanz zum jüngsten Jahresviertel (finanzen.net) |
Analysen zu Elanco Animal Health Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
Elanco Animal Health Inc Registered Shs | 11,44 | -3,30% | |
Eli Lilly | 786,70 | -0,11% |